Oppenheimer Starts Amarin Corporation (AMRN) at Underperform, $7 PT

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Oppenheimer Starts Amarin Corporation (AMRN) at Underperform, $7 PT

Gilead Sciences (GILD) 'Quietly' Added Amarin's (AMRN) Vascepa to an Old NASH Combo Trial - Raymond James

November 19, 2019 5:38 PM EST

Raymond James analyst Steven Seedhouse highlighted that Gilead Sciences (NASDAQ: GILD) has "quietly" added Amarin's (NASDAQ: AMRN) Vascepa to an old NASH combo trial.

The analyst commented, "We recently noticed a change to the clinical... More

Amarin Corp. (AMRN) Declines After Shares Hit with 'Underperform' Rating

November 19, 2019 4:29 PM EST

Amarin Corp. (NASDAQ: AMRN) declined post-market-close Tuesday after the stock was initiated with an Underperform rating and a price target of $7 at Oppenheimer. The stock declined about 3.5%.

... More